¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Mixed disorder of acid-base balance"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
¿µ¹® affective disorder ÇÑ±Û Á¤µ¿Àå¾Ö
¼³¸í   
  ÁַΠ±âºÐÀÇ Àå¾Ö°¡ ÁÖÃàÀÌ µÇ´Â ÀÏ·ÃÀÇ Á¤½ÅÀå¾ÖÀÌ´Ù. ÀÌ º´ÀÇ ¹üÁÖ¿¡´Â(¿ì¿ïº´£­Áö¼ÓÀûÀ¸·Î ¿ì¿ïÇÑ ±âºÐÀÌ ¿ÜºÎÀڱذú °ü°è¾øÀÌ ³ªÅ¸³ª´Â º´), (Á¶º´£­Áö¼ÓÀûÀ¸·Î µé¶á ±âºÐÀÌ ¿ÜºÎÀڱذú °ü°è¾øÀÌ °è¼ÓµÇ´Â º´) µîÀÌ Æ÷ÇԵȴÙ.
¿µ¹® psychiatric disorder(s) ÇÑ±Û Á¤½ÅÁúȯ
¼³¸í   
  Á¤½Å»óÅ¿¡ ÀÌ»óÀÌ Àִ ÁúȯÀ¸·Î, Á¤½ÅºÐ¿­º´, Á¤µ¿Àå¾Ö, ÀΰÝÀå¾Ö µîÀÌ ÀÖ´Ù.
¿µ¹® learning disorder ÇÑ±Û ÇнÀÀå¾Ö
¼³¸í   
  Áö´ÉÀº Á¤»óÀÌÁö¸¸ µè±â, ¸»Çϱâ, Àбâ, ¾²±â, Ã߸® ¶Ç´Â °è»ê´É·Â¿¡ ½É°¢ÇÑ ¹®Á¦°¡ ³ªÅ¸³ª´Â ¿©·¯ Àå¾ÖµéÀ» ÀÏÄ´ ¿ë¾î. À̷ΠÀÎÇØ Çо÷¼ºÀû ¹× Àڽۨ ÀúÇÏ, ´ëÀΰü°è¿¡¼­µµ »ç±³ ´É·ÂÀÌ ¹Ì¼÷ÇÏ¿© ÀÏ»ó»ýȰÀÇ ¸ðµç ¸é¿¡¼­ ¹®Á¦°¡ ³ªÅ¸³­´Ù. ¼ºÀα⠻çȸÀûÀÀ·Â¿¡µµ ¿µÇâÀ» ¹ÌÄ¥ ¼ö ÀÖÀ¸¸ç, ÇൿÀå¾Ö, ÁÖÀǷ°áÇÌ, °úÀ׿Àå¾Ö, ¿ì¿ïÀå¾Ö µî°ú µ¿¹ÝµÇ¾î ³ªÅ¸³¯ ¼ö ÀÖ´Ù. ±× À¯º´·üÀº ³·°Ô´Â 1.7%, ³ô°Ô´Â 30% Á¤µµ·Î ÃßÁ¤Çϰí ÀÖÁö¸¸ Çе¿±â ¾Æµ¿ÀÇ ¾à 3~9%°¡ ÀÌ Àå¾Ö¸¦ °®°í Àִ °ÍÀ¸·Î ¾Ë·ÁÁ® ÀÖ´Ù. ±âÃÊÇнÀ±â´É°Ë»ç¸¦ ÅëÇÏ¿© Áø´ÜÇÑ´Ù. ÇнÀÀÇ ±âȸ³ª ±³À°ÀûÀΠÀÚ±ØÀÌ ºÎÁ·ÇÑ °æ¿ì, ÁýÁ߷ ºÎÁ·, ¿ì¿ïÁõ-ºÒ¾È µî Á¤¼­Àû ¹®Á¦, ½Å°æÇÐÀû À̻󿡠ÀÇÇÑ °æ¿ì µîÀÌ ¿øÀÎÀÏ ¼ö ÀÖ´Ù. ÇнÀ°ú °ü·ÃÀÌ Àִ ³ú±â´É°ú ¿¬°üµÈ Æ¯Á¤¿µ¿ª¿¡ °áÇÔÀÌ Àְųª ¹ßÀ°Áö¿¬ ¶Ç´Â Àå¾Ö°¡ Àִ °æ¿ìµµ ¿øÀÎÀÌ µÈ´Ù. ¶ÇÇÑ ºÎ¸ð°¡ Á¶±â¿¡ ÀÚ³àÀÇ ´É·Â°ú Àû¼ºÀ» Àß ¾ËÁö ¸øÇϴ °æ¿ì¿¡µµ ¸¹ÀÌ »ý±ä´Ù.
¿µ¹® dissociative disorder ÇÑ±Û ÇØ¸®Àå¾Ö
¼³¸í   
  ÀǽÄ, µ¿ÀÛ, È¤Àº ÁÖü¼º µîÀÇ ÀΰÝÀÇ Á¤»óÀûÀΠÅëÇÕ±â´É¿¡ ±Þ°ÝÇϰí ÀϽÃÀûÀΠº¯È­°¡ ÀϾ¼­ Çϳª, ¶Ç´Â ±× ÀÌ»óÀÇ ±â´ÉÀÇ ¾î´À ºÎºÐÀÌ »ó½ÇµÇ´Â Á¤½ÅÁúȯÀ» Çظ®¼º Àå¾Ö¶ó°í ÇÑ´Ù. ÀÌ Áúȯ¿¡ ¼ÓÇϴ ´ëÇ¥ÀûÀΠ°ÍÀ¸·Î´Â ½ÉÀμº±â¾ï»ó½ÇÁõ(psychogenic amnesia), ´ÙÁßÀΰÝ(multiple personality), µÐÁÖ(fugue) µîÀÌ ÀÖ´Ù. ½ÉÀμº ±â¾ï»ó½ÇÁõÀ̶õ Á¤½ÅÀûÀΠÅëÇÕ±â´É Áß¿¡¼­ Æ¯È÷ ÀǽÄÀÇ ±Þ°ÝÇϰí ÀϽÃÀûÀΠº¯È­°¡ ÀϾ¼­ ³úÀÇ Àå¾Ö¾øÀÌ °ú°ÅÀÇ ÀÏÀ» ±â¾ïÇÏÁö ¸øÇϴ °ÍÀ» ¸»ÇÑ´Ù. ´ÙÁßÀΰÝÀ̶õ ÇÑ °¡Áö ÀÌ»óÀÇ ÀΰÝÀÌ »ç¶÷¿¡°Ô Á¸ÀçÇϴ °ÍÀ¸·Î Æ¯Á¤ÇÑ ÀΰÝÀº ÀÏÁ¤ ±â°£µ¿¾È ±× »ç¶÷À» Áö¹èÇÏ°í ±× Àΰݠ°¢°¢Àº ±× ³ª¸§ÀǠü°è¸¦ °¡Áö°í Àΰ£°ü°è¸¦ Çü¼ºÇϴ °ÍÀÌ ´ëºÎºÐÀÌ´Ù. µÐÁÖ¶õ ÀÚ½ÅÀÇ ÁÖü¿¡ ´ëÇÑ ±â¾ïÀ» »ó½ÇÇÏ°í »õ·Î¿î ÁÖü¼ºÀ» °¡Áö°í °¡Á¤À̳ª Á÷ÀåÀ» ¶°³ª¼­ ¿¹Á¤¿¡ ¾ø´ø ¿©ÇàÀ» °©ÀÛ½º·´°Ô Çϴ °ÍÀ¸·Î ´ë°³ Åë»óÀûÀΠ»óȲ¿¡¼­´Â °ÅÀÇ ÀϾÁö ¾Ê°í Àü½Ã, ÃµÀçÁöº¯¿¡¼­ ÀÚÁÖ ÀÖ°í µÐÁÖ¿¡¼­ÀǠȸº¹Àº ±ÞÀÛ½º·´°Ô ÀϾ°í Àç¹ßÀº °ÅÀÇ ¾ø´Ù. Çظ®¼º Àå¾ÖÀÇ ´ëºÎºÐÀº È¸º¹ÀÌ µÉ °æ¿ì¿¡´Â ¹ßº´±â°£ Áß¿¡ ÀÖ¾ú´ø ÀÏÀ» ±â¾ïÇØ ³»Áö ¸øÇϴ °ÍÀÌ ´ëºÎºÐÀÌ´Ù.
¿µ¹® behavior disorder ÇÑ±Û ÇൿÀå¾Ö
¼³¸í   
  Á¤½ÅÀå¾Ö¸¦ °¡¸®Å°´Âµ¥ »ç¿ëµÇ´Â ¿ë¾î·Î¼­, Æ¯È÷ ÁöÀû, °¨Á¤Àû, ÇൿÀû Á¤½ÅÀå¾ÖÀ̸ç, ±âÁúÀû Àå¾Ö°¡ À־ »ý±â´Â °ÍÀº ¾Æ´Ï´Ù. Áö¼ÓÀûÀ¸·Î Å¸ÀÎÀÇ ±Ç¸®¸¦ Ä§¹üÇϰųª ³ªÀÌ¿¡ °É¸ÂÁö ¾Ê°Ô »çȸÀû ±Ô¹üÀ» ¾î±â´Â ÇൿÀÌ ³ªÅ¸³ª´Â Àå¾Ö·Î¼­, µµ½Ã¿¡¼­ ´õ ¸¹ÀÌ ³ªÅ¸³ª´Â °æÇâÀÌ ÀÖ´Ù. Á¤½ÅºÐ¼®ÇÐÀûÀΠ°ßÇØ¿¡ ÀÇÇϸ頵µ´öÀû ÃÊÀھư¡ ¼ºÀåÇÏÁö ¸øÇÏ¿© ³ªÅ¸³ª°Å³ª ºÎ¸ðÀÇ ¹«ÀǽÄÀûÀÌ°í ¹Ý»çȸÀû Ã浿ÀÌ ¾î¸°ÀÌ¿¡°Ô Àü´ÞµÇ¾î ÇൿȭÇϴ °ÍÀ̶ó°í ÇÑ´Ù. °¡Á¤È¯°æÀû ¿øÀÎÀ¸·Î´Â °á¼Õ°¡Á¤, ºÎ¸ðÀÇ °¥µî, ¾ËÄڿàÁßµ¶, ¾à¹°³²¿ë, ¹Ý»çȸÀû Çൿ µîÀ» µ¿¹ÝÇÑ ¾Æ¹öÁöÀÇ Á¤½Åº´¸®, Àϰü¼º ¾ø´Â ÈÆÀ°, ¾Æµ¿Çдë, ¾î¸Ó´ÏÀÇ ¿ì¿ïÁõ µîÀ» µé ¼ö ÀÖ´Ù. »ý¹°ÇÐÀû ¿äÀÎÀ¸·Î´Â À¯ÀüÀûÀ¸·Î Æ¯Á¤ À¯ÀüÁúº´À» ¾Î´Â È¯ÀÚÀÇ °æ¿ì¿¡ Æø·Â¼ºÀÌ µÎµå·¯Áö°Ô ³ªÅ¸³ª´Â °ÍÀ¸·Î º¸°íµÇ¾î ÀÖ°í, ³ú¼Õ»ó°ú ³úÆÄ ÀÌ»ó, °æ¹ÌÇÑ ½Å°æÇÐÀû ÀÌ»ó, È£¸£¸ó ºÒ±ÕÇü µîµµ ±× ¿øÀÎÀÌ µÇ´Â °ÍÀ¸·Î ¾Ë·ÁÁ® ÀÖ´Ù. ÀÌ Àå¾Ö´Â ´ëºÎºÐ ÇнÀÀå¾Ö, ÁÖÀǷ °áÇÌ, °úÀ׿Àå¾Ö, ¿ì¿ïÀå¾Ö, ºÒ¾ÈÀå¾Ö, ¾à¹°³²¿ë µî°ú ÇÔ²² ³ªÅ¸³­´Ù. ¹Ì±¹ÀÇ Åë°è¿¡ ÀÇÇϸé 18¼¼ ÀÌÇÏÀÇ ³²¼º 6~16%, ¿©¼º 2~9%°¡ ÀÌ Àå¾Ö¸¦ °¡Áö°í Àִ °ÍÀ¸·Î º¸°íµÇ¾î ÀÖ´Ù. Çѱ¹ÀÇ °æ¿ì ÃʵîÇб³ 4~6Çг⠾ÀÌ Áß ³²¾Æ 5%, ¿©¾Æ 2.3%°¡ ÀÌ Àå¾Ö¸¦ °¡Áö°í Àִ °ÍÀ¸·Î º¸°íµÇ¾ú´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • mixed lymphocyte culture test
    È¥ÇÕ¸²ÇÁ±¸¹è¾ç°Ë»ç
  • mixed lymphocyte reaction
    ¸²ÇÁ±¸È¥ÇÕ¹è¾ç¹ÝÀÀ
  • mixed nerve
    È¥ÇսŰæ
  • mixed order reaction
    È¥ÇÕ¼ø¼­¹ÝÀÀ
  • mixed pineocytoma
    È¥ÇÕ¼Ö¹æ¿ï»ùÁ¾, È¥ÇÕ¼Û°úüÁ¾
  • mixed psychosis
    È¥ÇÕÁ¤½Åº´
  • mixed tumor
    È¥ÇÕÁ¾¾ç
  • mixed vaccine
    È¥ÇÕ¹é½Å
  • antisocial personality disorder
    ¹Ý»çȸÀûÀΰÝÀå¾Ö
  • anxiety disorder
    ºÒ¾ÈÀå¾Ö
  • anxious personality disorder
    ºÒ¾ÈÀΰÝÀå¾Ö
  • articulation disorder
    ¹ßÀ½Àå¾Ö
  • asocial personality disorder
    ºñ»çȸÀûÀΰÝÀå¾Ö
  • attention deficit disorder
    ÁÖÀǷ°áÇÌÀå¾Ö
  • attention deficit hyperactivity disorder
    ÁÖÀǷ°áÇ̰ú´ÙȰµ¿Àå¾Ö
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 14 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • platelet function disorder
    Ç÷¼ÒÆÇ±â´ÉÀÌ»ó
  • premenstrual dysphoric disorder
    ¿ù°æÀüºÒÄèÀå¾Ö, ¿ù°æÀüºÒÄ躴
  • psychogenic disorder
    Á¤½ÅÅ¿Àå¾Ö, ½ÉÀμºÀå¾Ö
  • reading disorder
    ÀбâÀå¾Ö
  • renal disorder
    ÄáÆÏÀå¾Ö, ½ÅÀåÀå¾Ö
  • schizophreniform disorder
    Á¤½ÅºÐ¿­ÇüÀå¾Ö, Á¤½ÅºÐ¿­Çüº´
  • seizure disorder
    ¹ßÀÛÀå¾Ö
  • sexual disorder
    ¼ºÀå¾Ö
  • somatic disorder
    ½ÅüÀå¾Ö
  • somatization disorder
    ½ÅüȭÀå¾Ö
  • somatoform disorder
    ½ÅüÇüÀå¾Ö, ½ÅüÇüº´
  • sweating disorder
    ¶¡Àå¾Ö
  • thought disorder
    »ý°¢Àå¾Ö, »ç°íÀå¾Ö
  • vascular disorder
    Ç÷°üÁúȯ, Ç÷°üÀå¾Ö
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • mixed nerve
    È¥ÇսŰæ
  • mixed pineocytoma
    È¥ÇÕ¼Ö¹æ¿ï»ùÁ¾
  • mixed psychosis
    È¥ÀçÁ¤½Åº´
  • mixed sequence
    º¹ÇÕ¿¬¼â
  • mixed spicule
    È¥ÇÕħ°ñ
  • mixed tumor
    È¥ÇÕÁ¾¾ç
  • mixed vaccine
    È¥ÇÕ¹é½Å
  • mixed germ cell tumor
    È¥ÇÕ¹è¾Æ¼¼Æ÷Á¾¾ç
  • mixed lymphocyte reaction
    ¸²ÇÁ±¸È¥ÇÕ¹è¾ç¹ÝÀÀ
  • mixed lymphocyte culture test
    È¥ÇÕ¸²ÇÁ±¸¹è¾ç°Ë»ç
  • mixed order reaction
    È¥ÇÕÂ÷¹ÝÀÀ
  • mixed suspended solid
    È¥ÇÕºÎÀ¯°íÇü¹°
  • adhesion deficiency disorder
    À¯Âø°áÇÌÀå¾Ö
  • adjustment disorder
    ÀûÀÀÀå¾Ö
  • affective disorder
    Á¤µ¿Àå¾Ö, Á¤µ¿º´
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • acute polymorphic psychotic disorder
    ±Þ¼º ´ÙÇü¼º Á¤½ÅÁõÀû Àå¾Ö(º´)
  • acute stress disorder
    ±Þ¼º ½ºÆ®·¹½º Àå¾Ö(º´)
  • adjustment disorder
    ÀûÀÀÀå¾Ö(º´)
  • adjustment sleep disorder
    ÀûÀÀ¼º ¼ö¸éÀå¾Ö(º´), ¼ö¸é Á¶Á¤ Àå¾Ö(º´)
  • affective disorder
    °¨µ¿¼º Á¤½Åº´, Á¤µ¿¼º Á¤½ÅÀå¾Ö(¡­ïñãêî¡äô).
  • allergic disorder
    ¾Ë·¹¸£±â(¼º) Áúȯ.
  • antisocial personality disorder
    ¹Ý»çȸ¼º ÀΰÝÀå¾Ö
  • anxiety disorder
    ºÒ¾È Àå¾Ö(º´)
  • arithmetic disorder
    »ê¼úÀå¾Ö(º´)
  • fructose-related disorder
    ÇÁ¶ôÅ佺°ü·ÃÀå¾Ö<--Áúº´>
  • functional disorder
    ±â´É¼º Àå¾Ö.
  • generalized anxiety disorder
    ¹üºÒ¾ÈÀå¾Ö(ÛñÝÕäÌî¡äô)(º´)
  • genetic disorder
    À¯ÀüÀû Àå¾Ö
  • hallucinogen use disorder
    ȯ°¢Á¦»ç¿ëÀå¾Ö(º´)(ü³ÊÆð¥ÞÅéÄî¡äô)
  • hallucinogen-induced disorder
    ȯ°¢Á¦ À¯¹ß¼ºÀå¾Ö(º´)(ü³ÊÆð¥ë¯Û¡àõî¡äô)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • negative balance
    À½¼º±ÕÇü(ëäàõгû¬).
  • negative nitrogen balance
    À½¼ºÁú¼ÒÆòÇü (~òòáÈøÁû¬), ¼Ò½Ç¼º Áú¼Ò
  • negative water balance
    À½¼º¼öºÐ±ÕÇü.
  • nitrogen balance
    Áú¼Ò±ÕÇü.
  • occlusal balance
    ±³ÇÕ±ÕÇü.
  • oxygen balance
    »ê¼ÒÆòÇü(¡­øÁû¬).
  • physiological balance
    »ý¸®Àû ÆòÇü<±ÕÇü>.
  • positive balance
    ¾ç¼º¼öÁö.
  • positive nitrogen balance
    ¾ç¼ºÁú¼ÒÆòÇü.
  • prescription balance
    Á¶Á¦Àú¿ï, Á¶Á¦ÃµÄª (¡­ô¸öß).
  • roman balance
    ´ëÀú¿ï.
  • sodium balance
    ¼Òµð¿òÆòÇü.
  • sodium chloride balance test
    ¿°È­³ªÆ®·ýÆòÇü½ÃÇè(¡­øÁû¬ãËúÐ).
  • solvent balance
    ¿ë¸ÅÆòÇü(¡­øÁû¬).
  • surface tension balance
    Ç¥¸éÀå·ÂÆòÇü.
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
ABLB alternate binaural loudness balance
AMLB alternate monoaural loudness balance
bal balance; balsam
BALB binaural alternate loudness balance
BGS balance, gait, and station; blood group substance; British Geriatrics Society
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
MC Mixed Cellularity
M.C.T.D. Mixed Connective Tissue Disease
MC Mixed Cryoglobulinemia
MLC Mixed Leukocyte Culture
MLL Mixed Lineage Leukaemia
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • mixed lymphocyte culture
    È¥ÇÕ ¸²ÇÁ±¸ ¹è¾ç
  • mixed mesodermal tumor
    È¥ÇÕ Á߹迱¼º Á¾¾ç, È¥ÇÕ¼º Á߹迱¼º Á¾¾ç
  • mixed muscular vascular headache
    ±Ù¸Æ°ü¼º È¥ÇÕ µÎÅë, È¥ÇÕµÈ ±Ù-Ç÷°ü¼º µÎÅë, È¥ÇÕ¼º ±ÙÀ° Ç÷°ü µÎÅë, È¥ÇÕÇü ±Ù¸Æ°ü¼º µÎÅë
  • mixed odontogenic tumor
    È¥ÇÕ Ä¡¼º Á¾¾ç
  • mixed paralysis
    È¥ÇÕ ¸¶ºñ
    ¿îµ¿°ú °¨°¢ÀÇ ¿¬ÇÕ ¸¶ºñ.
  • mixed race
    È¥Ç÷ ÀÎÁ¾
  • mixed salivary gland
    º¹ÇÕ Ä§»ù, È¥ÇÕ Å¸¾×¼±
  • mixed small and large cell lymphoma
    È¥ÇÕ¼º ´ë¼Ò¼¼Æ÷ ¸²ÇÁÁ¾
  • mixed tumor
    È¥ÇÕÁ¾, È¥ÇÕ Á¾¾ç
    µ¿ÀǾî=
  • mixed vaccine
    È¥ÇÕ ¹é½Å
    µÎ Á¾·ù ÀÌ»óÀÇ ¿¹¹æÁ¢Á¾ Àç·á¸¦ È¥ÇÕÇÑ ¹é½Å. È¥ÇÕÇÔÀ¸·Î½á °¢ ¼ººÐÀÇ ¸é¿ª¿ø¼º¿¡ °¨¼ÕÀÌ ¾ø´Â °æ¿ì ÇàÇÏ¿©Áø´Ù. °¡Àå º¸ÆíÀûÀ¸·Î ¾²À̰í ÀÖ´Â °Í¿¡´Â ÀåÆ¼Çª½º¿Í ÆÄ¶óƼǪ½ºÀÇ È¥ÇÕ ¹é½Å, ÀÎÇ÷翣ÀÚ ¹ÙÀÌ·¯½ºÀÇ AÇü°ú BÇüÀÇ È¥ÇÕ ¹é½Å µîÀÌ ÀÖ´Ù. ÀåÆ¼Çª½º, ÆÄ¶óƼǪ½º È¥ÇÕ ¹é½ÅÀº ÀåÆ¼Çª½º±Õ°ú A±Õ ¹× ÆÄ¶óƼǪ½º B±ÕÀ» »ì±ÕÇÏ¿© ÀÏÁ¤ÇÑ ºñÀ²·Î È¥ÇÕÇÑ °ÍÀ¸·Î¼­, ÇÇÇÏ ÁÖ»ç ¶Ç´Â Çdz» ÁÖ»çÇÑ´Ù.
  • mixed venous blood
    È¥ÇÕ Á¤¸ÆÇ÷
  • monogerminal mixed tumor
    ´Ü ¹è¿±¼º È¥ÇÕ Á¾¾ç
  • odontogenic mixed tumor
    Ä¡¿ø È¥ÇÕ Á¾¾ç
  • acquired disorder
    ÈÄõ¼º Àå¾Ö
    ¼±ÃµÀûÀÌ ¾Æ´Ï°í Ãâ»ý ÈÄ Á¤»óÀûÀÎ ¹ßÀ°¿¡ ÀÌ»óÀÌ »ý±â°Å³ª, º¯È­°¡ ¿À°Å³ª, Àå¾Ö°¡ ÀϾ °Í.
  • acute brain disorder
    ±Þ¼º ³úÀå¾Ö
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
mixed hyperlipidemia mixed hyperlipoproteinaemia familial, type 5 hyperlipidemia
mixed hyperlipoproteinaemia familial Type 5 hyperlipidemia, elevations of VLDL and chylomicrons found in plasma.
Synonym: mixed hyperlipidemia.
(05 Mar 2000)
mixed hypoglycaemia Hypoglycaemia due to more than one cause.
(05 Mar 2000)
mixed infection Infection by more than one variety of pathogenic microorganisms.
(05 Mar 2000)
mixed lymphocyte culture <investigation> Test to determine whether a patients and donor's white blood cells interact adversely. Often used to determine whether a person would be a suitable bone marrow donor for a particular patient.
(16 Dec 1997)
mixed lymphocyte culture test Measure of histocompatibility at the hl-a locus. Peripheral blood lymphocytes from two individuals are mixed together in tissue culture for several days. Lymphocytes from incompatible individuals will stimulate each other to proliferate significantly (measured by tritiated thymidine uptake) whereas those from compatible individuals will not. In the one-way mlc test, the lymphocytes from one of the individuals are inactivated (usually by treatment with mitomycin c or radiation) thereby allowing only the untreated remaining population of cells to proliferate in response to foreign histocompatibility antigens.
(12 Dec 1998)
mixed lymphocyte reaction <haematology, immunology, investigation> Reaction of mitogenesis produced in T lymphocytes when allogeneic (i.e. Mixed) lymphocytes are brought together, provided they are mismatched in histocompatibility loci. Once used as a test for possible graft compatibility in human grafting. Now known that a negative reaction is a poor predictor of graft acceptance.
(18 Nov 1997)
mixed mesodermal tumour A sarcoma of the body of the uterus arising in older women, composed of more than one mesenchymal tissue, especially including striated muscle cells.
Synonym: malignant mixed mullerian tumour.
(05 Mar 2000)
mixed nerve <anatomy, nerve> A nerve containing both afferent and efferent fibres.
(05 Mar 2000)
mixed opioid agonist-antagonist <pharmacology> A compound that has an affinity for two or more types of opioid receptors and blocks opioid effects on one receptor type while producing opioid effects on a second receptor type.
(13 Nov 1997)
mixed paralysis Combined motor and sensory paralysis.
(05 Mar 2000)
mixed sleep apnoea <chest medicine> A form of sleep apnoea where there is exists a combination of obstructive and central sleep apnoea syndromes.
(13 Nov 1997)
mixed thrombus A laminated thrombus, the layers of different ages being of different colour or consistency.
Synonym: stratified thrombus.
(05 Mar 2000)
mixed tide <ecology, marine biology> Tidal cycle in which there are usually two high and two low tides during a day.
(13 Nov 1997)
mixed tumour A tumour composed of two or more varieties of tissue.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • mixed metaphor
    È¥À¯
  • mixed number
    ´ëºÐ¼ö
  • mixed tithe
    (°¡Ãà·ù¿¡¼­ÀÇ ¼öÀÍ¿¡ ´ëÇÑ) 10ºÐÀÇ 1ÀÇ ¼¼
  • mixed train
    (°´Â÷¿Í È­Â÷ÀÇ) È¥¼º ¿­Â÷
  • ready-mixed
    ¹Ì¸® Á¶Á¦(Á¶ÇÕ,È¥ÇÕ)ÇÑ
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á